As COVID-19 has transformed our communities, nation, and world, IU researchers have worked to advance understanding of the virus, test vaccines, and develop protections while also keeping policymakers, industry and community leaders, journalists, and the public informed. Read on to learn about some of the remarkable research and collaborative partnerships created as part of our shared fight against COVID-19.
Fighting a pandemic with research and scholarship
Description of the video:
Music plays
Image of coronavirus moves on screen
Text A global pandemic is threatening lives.
Image of woman sitting inside on couch.
Text: Sowing fear.
Image of empty urban streets.
Text: And changing how we see the world.
Overhead image of empty urban streets.
Text: But even when the world stops …
Image of Sample Gates on the IU Bloomington campus
Text: Hoosier researchers keep going.
Music gets louder and faster
Image of woman donning a face mask.
Text: We’re fighting the virus head-on.
Image of person in orange hazmat suit approaching a hospital room.
Text: Collaborating with other experts in business, government and medicine.
Image of woman in PPE looking through microscope in medical facility.
Text: Creating a vaccine to protect children.
Image of man putting on special face mask
And developing COVID-killing masks.
Images of virus particles.
Headlines of stories about IU research drop on to the screen.
Text: Our public health experts are shaping critical response efforts …
Text: Responding to the racial inequity of COVID-19 and saving lives.
Image of rural green forested land
Text: And we’re partnering to track coronavirus across rural Indiana.
Image of woman in PPE administering COVID-19 test to person in car wearing mask.
Text: We launched the nation’s first statewide study to shape Indiana’s pandemic response.
Image of man and woman with microscope working in a lab.
Text: We rise to the challenge.
Text: As researchers and leading experts.
Overhead image of the IU Bloomington campus
Text: Because that’s what Hoosiers everywhere deserve.
Image of microscope
Text: We rise to the challenge
Overhead image of a clock tower on the IU Bloomington campus.
Text: Because we are Indiana’s university.
Screen fades to read, with IU logo and research.impact.iu.edu.
Music stops.
Featured stories
Looking for clarity about COVID 'long-haulers'
A study co-authored by IU School of Medicine's Natalie Lambert digs in to the persistent symptoms frequently reported throughout the pandemic by patients known as “long-haulers”.
Read more
COVID-19 hospitalizations increased as a result of state reopenings
A new study by IU researchers in collaboration with University of Minnesota, found that the daily trend in hospitalizations increased following state reopenings in summer 2020, resulting in over 5,300 new people being hospitalized for COVID-19 each day.
Read more
Pursuing a COVID-19 vaccine for kids
Since the pandemic struck the United States more than a year ago, IU Bloomington virologist John Patton, graduate student Asha Philip, and others have been working on a COVID-19 vaccine for young children, based on a well-established vaccine for the common childhood illness rotavirus.
Read more
Gut microbes may be key in fighting viral infections, including COVID-19
In a recent National Geographic article, IU School of Medicine microbiologist Bill Sullivan considers how our gut's microbes may be drafted to help fight viral invaders.
Read more
Why some parents do not plan to vaccinate their children
More than a quarter of all U.S. parents say they do not intend to vaccinate their children against COVID-19, according to preliminary results from a study by Indiana University researchers.
Read more
What's behind inconsistent results for COVID-19 drug trials?
An effective antiviral drug for COVID-19 would have significant global health benefits, but clinical trials have produced inconsistent results. New IU research suggests that significant variation in the amount of virus from person to person may be a contributing factor and that recruiting participants shortly after symptoms begin could be key.
Read more-
Kelley professor joins national committee studying U.S. medical product supply chain
George Ball will join a committee evaluating the United States' dependence on drugs and devices sourced or manufactured outside the country.
-
What underlies inconsistent results in clinical trials for COVID-19 drugs?
The study suggests that recruiting patients to COVID-19 drug trials as early as possible after symptom onset may address inconsistencies.
-
Masks now optional for fully vaccinated on IU campuses
As more IU students, faculty and staff are fully vaccinated, the university moved up the start date for this mask policy change.
-
Hoosiers express greater concern about future pandemics, climate change
A new survey reveals that Indiana residents are more concerned about a future disease outbreak than they were before 2020.
-
Fairbanks School of Public Health earns AcademyHealth award for Indiana COVID-19 Prevalence Study
A team of IUPUI faculty and staff are recipients of the AcademyHealth Health Services Research Impact award for their work on the study.